3 completed, 2 terminated. 5 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 3, Terminated 2 |
| Phase 1 | 2 | Terminated 2 |
Follow Western Blot: new trials by email Literature Review of Western Blot trials Research Report on Western Blot
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma panobinostat, laboratory biomarker analysis, western blotting - Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma | Phase 2 | Completed | Mayo Clinic | 41 | 2011-01-17 | 2022-05-24 |
| Entinostat And Imatinib Mesylate In Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia entinostat, imatinib mesylate, laboratory biomarker analysis - Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | Terminated | National Cancer Institute (NCI) | 2 | 2010-10-01 | 2017-08-08 |
| Pegfilgrastim and Rituximab in Treating Patients With Untreated, Relapsed, or Refractory Follicular Lymphoma, Small Lymphocytic Lymphoma, or Marginal Zone Lymphoma pegfilgrastim, rituximab, flow cytometry - Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma | Phase 2 | Completed | Roswell Park Cancer Institute | 20 | 2007-04-17 | 2017-10-09 |
| Sorafenib Tosylate and Gene Expression Analysis in Patients Undergoing Surgery For High-Risk Localized Prostate Cancer sorafenib tosylate, microarray analysis, immunohistochemistry staining method - Adenocarcinoma of the Prostate, Stage II Prostate Cancer | Phase 2 | Completed | University of Washington | 5 | 2006-12-01 | 2017-11-22 |
| Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma nelfinavir mesylate, biopsy, laboratory biomarker analysis - Adult Liposarcoma, Recurrent Adult Soft Tissue Sarcoma | Phase 1 / Phase 2 | Terminated | City of Hope Medical Center | 29 | 2006-03-01 | 2015-04-01 |
Leukemia, Lymphocytic, Chronic, B-Cell (2) · Lymphoma, B-Cell, Marginal Zone (2) · Lymphoma, Follicular (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Burkitt Lymphoma (1) · Immunoblastic Lymphadenopathy (1) · Liposarcoma (1) · Lymphoma, Extranodal NK-T-Cell (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Large-Cell, Anaplastic (1) · Lymphoma, Mantle-Cell (1) · Lymphoma, T-Cell, Peripheral (1) · Mycosis Fungoides (1) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1) · Prostatic Neoplasms (1)
City of Hope Medical Center (1) · Mayo Clinic (1) · National Cancer Institute (NCI) (1) · Roswell Park Cancer Institute (1) · University of Washington (1)
United States (5)
Evan Yu (1) · Francisco Hernandez-ILizaliturri (1) · Patrick Brown (1) · Patrick Johnston, M.D. (1) · Warren Chow (1)
U01CA070095 (1)